Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Will not enforce circular on hospital medicine price disclosure for now: Karnataka government to HC

2 days ago 1

PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

It was contended on behalf of the petitioners that the FSDA had no statutory power to impose such conditions for disclosure of purchase price. | Image for representational purposes only

It was contended on behalf of the petitioners that the FSDA had no statutory power to impose such conditions for disclosure of purchase price. | Image for representational purposes only | Photo Credit: JK1991

The State government on Friday (October 30) told the Karnataka High Court that it would not insist, for now, on the implementation of the circular which mandates that all hospital pharmacies disclose the landing base/purchase price and maximum retail price (MRP) of medicines, medical devices and consumables on bills.

An undertaking in this regard was given to the court on behalf of the State’s Food Safety and Drug Administration (FSDA) during the hearing of a petition filed by Private Hospitals and Nursing Homes Association, Bengaluru, and a private hospital. The petitioners have challenged the legality of the October 1 circular.

Justice C.M. Pooncha, before whom the petition came up for hearing, has adjourned further hearing on the petition till November 12 after recording the undertaking given by an Additional Advocate General on instruction from the officials of the FSDA.

Having a re-look

The government also informed the court that “the officials concerned are in the process of having a re-look at the circular dated October 1, 2026, and will not enforce the mandate of the circular till November 12, the next date of hearing on the petition”.

The undertaking was given while requesting the court not to stay the circular to allow the government to re-examine the issues raised by the petitioners.

It was contended on behalf of the petitioners that the FSDAhad no statutory power to impose such conditions for disclosure of purchase price, which is a commercial agreement between the sellers and buyers that vary depending on suppliers, purchase quantity, discounts, credit arrangements and other factors.

Sans consultation

Mandating disclosure of purchase price would result in exposing confidential commercial arrangements between the suppliers and health establishments, it has been contented in the petition, while pointing out that the circular was issued sans adequate consultations with the stakeholders, even though the circular has direct implications on their finance.

Published - October 30, 2026 08:52 pm IST

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway